Form 4: Lexeo Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc., sold 4,117 shares of common stock on August 18, 2026 for $4.91 per share.
Summary
- Open-market sale: disposed of 4,117 Common Stock at $4.91 ($20,203) on August 18, 2026; holds 92,907 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $20,203 of stock on the open market.
Insider Transactions
Louis Edward Tamayo — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 4,117 | $5 | $20.2K | 92,907 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (4,117 shares) |
Keywords
insider transaction, Form 4, LXEO, Lexeo Therapeutics, Inc., bearish, Louis Edward Tamayo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.